Biogen Financial Statements From 2010 to 2025

Biogen Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 29.5 B 28 B 20.1 B Slightly volatile Short and Long Term Debt Total 7 B 6.6 B 4.9 B Slightly volatile Other Current Liabilities 2.9 B 2.8 B 2.2 B Slightly volatile Total Current Liabilities 5.8 B 5.5 B 3.1 B Slightly volatile Total Stockholder Equity 17.6 B 16.7 B 11.1 B Slightly volatile Property Plant And Equipment Net 3.7 B 3.5 B 2.8 B Slightly volatile Cash 2.5 B 2.4 B 1.6 B Slightly volatile Non Current Assets Total 21.6 B 20.6 B 13.8 B Slightly volatile Non Currrent Assets Other 715.7 M 560.5 M 1.4 B Pretty Stable Cash And Short Term Investments 1.5 B 2.4 B 2.7 B Slightly volatile Net Receivables 2 B 1.9 B 1.6 B Slightly volatile Common Stock Shares Outstanding 138.6 M 145.9 M 209 M Slightly volatile Liabilities And Stockholders Equity 29.5 B 28 B 20.1 B Slightly volatile Non Current Liabilities Total 3.2 B 5.8 B 5.7 B Slightly volatile Other Current Assets 404.2 M 752.5 M 747.7 M Slightly volatile Total Liabilities 11.9 B 11.3 B 9 B Slightly volatile Property Plant And Equipment Gross 6.5 B 6.2 B 3.3 B Slightly volatile Total Current Assets 7.8 B 7.5 B 6.3 B Slightly volatile Intangible Assets 10.2 B 9.7 B 4.1 B Slightly volatile Accounts Payable 445.4 M 424.2 M 343.4 M Slightly volatile Common Stock Total Equity 85.5 K 90 K 119.9 K Slightly volatile Common Stock 85.5 K 90 K 119.9 K Slightly volatile Short Term Debt 1.8 B 1.7 B 535.2 M Slightly volatile Inventory 2.6 B 2.5 B 1.1 B Slightly volatile Other Liabilities 969.6 M 1.5 B 1.4 B Slightly volatile Other Assets 2 B 1.9 B 1.4 B Slightly volatile Long Term Debt 3 B 4.5 B 4.2 B Slightly volatile Property Plant Equipment 2.1 B 3.8 B 2.6 B Slightly volatile Good Will 3.3 B 6.5 B 3.9 B Slightly volatile Net Tangible Assets 4.1 B 6.7 B 4.1 B Slightly volatile Retained Earnings Total Equity 11.5 B 18.9 B 12 B Slightly volatile Long Term Debt Total 4.3 B 7.2 B 4.4 B Slightly volatile Capital Surpluse 62.7 M 66 M 1.4 B Slightly volatile Deferred Long Term Liabilities 631.7 M 384.9 M 574.4 M Pretty Stable Non Current Liabilities Other 1 B 732.3 M 991.1 M Slightly volatile Short and Long Term Debt 1.8 B 1.7 B 556.4 M Slightly volatile Net Invested Capital 19.8 B 23 B 18.4 B Very volatile Net Working Capital 3.1 B 1.9 B 4.1 B Slightly volatile Capital Stock 80 K 90 K 98.1 K Slightly volatile Deferred Long Term Asset Charges 3 B 3.7 B 2.6 B Slightly volatile Capital Lease Obligations 295 M 334.5 M 388.9 M Slightly volatile
Biogen Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 706.9 M 673.2 M 513 M Slightly volatile Selling General Administrative 2.5 B 2.4 B 1.9 B Slightly volatile Total Revenue 10.2 B 9.7 B 9.5 B Slightly volatile Gross Profit 3.9 B 7.4 B 7.6 B Slightly volatile Other Operating Expenses 7.8 B 7.5 B 6.2 B Slightly volatile Cost Of Revenue 2.4 B 2.3 B 1.5 B Slightly volatile Total Operating Expenses 5.4 B 5.1 B 4.5 B Slightly volatile Income Tax Expense 395.2 M 273.8 M 776.8 M Very volatile Research Development 1.4 B 2 B 2 B Slightly volatile Net Income Applicable To Common Shares 2 B 3.5 B 2.8 B Slightly volatile Net Income From Continuing Ops 2.8 B 1.6 B 2.7 B Pretty Stable Non Recurring 99.1 M 118 M 120.5 M Pretty Stable Selling And Marketing Expenses 93.1 M 82.1 M 81.2 M Slightly volatile Tax Provision 260.1 M 273.8 M 974.8 M Slightly volatile Interest Income 106.2 M 67.6 M 99.8 M Very volatile Reconciled Depreciation 525.7 M 673.2 M 834.4 M Slightly volatile
Biogen Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 786.4 M 1 B 1.4 B Slightly volatile Capital Expenditures 381.3 M 359.8 M 616.1 M Pretty Stable Net Income 1.3 B 1.6 B 2.5 B Pretty Stable End Period Cash Flow 2.5 B 2.4 B 1.6 B Slightly volatile Stock Based Compensation 201.3 M 291.2 M 172.3 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.19 2.3027 10.4905 Slightly volatile Dividend Yield 0.0028 0.0023 0.0021 Slightly volatile PTB Ratio 1.27 1.3329 5.2905 Slightly volatile Days Sales Outstanding 78.72 70.496 65.6069 Slightly volatile Book Value Per Share 120 115 62.372 Slightly volatile Stock Based Compensation To Revenue 0.0263 0.0301 0.0185 Slightly volatile PB Ratio 1.27 1.3329 5.2905 Slightly volatile EV To Sales 2.61 2.7425 10.5789 Slightly volatile Inventory Turnover 0.89 0.939 1.427 Very volatile Days Of Inventory On Hand 201 389 273 Slightly volatile Payables Turnover 5.62 5.4465 4.9371 Pretty Stable Sales General And Administrative To Revenue 0.22 0.28 0.2121 Very volatile Research And Ddevelopement To Revenue 0.32 0.211 0.2471 Slightly volatile Capex To Revenue 0.0353 0.0372 0.0811 Slightly volatile Cash Per Share 17.12 16.3006 14.9453 Slightly volatile Interest Coverage 8.42 8.865 36.4448 Slightly volatile Payout Ratio 0.74 0.46 0.455 Very volatile Days Payables Outstanding 63.66 67.0157 84.0421 Pretty Stable Intangibles To Total Assets 0.61 0.5765 0.3721 Slightly volatile Current Ratio 1.28 1.3487 2.4784 Slightly volatile Tangible Book Value Per Share 6.44 3.7467 15.2035 Very volatile Receivables Turnover 6.15 5.1776 5.7391 Slightly volatile Graham Number 179 170 132 Slightly volatile Shareholders Equity Per Share 120 115 62.3651 Slightly volatile Debt To Equity 0.42 0.3966 0.3983 Slightly volatile Capex Per Share 2.59 2.4695 2.9739 Very volatile Revenue Per Share 69.73 66.4097 52.2341 Slightly volatile Interest Debt Per Share 49.59 47.2244 29.2342 Slightly volatile Debt To Assets 0.25 0.2364 0.2105 Slightly volatile Short Term Coverage Ratios 1.56 1.6445 335 Slightly volatile Operating Cycle 482 459 313 Slightly volatile Price Book Value Ratio 1.27 1.3329 5.2905 Slightly volatile Days Of Payables Outstanding 63.66 67.0157 84.0421 Pretty Stable Dividend Payout Ratio 0.74 0.46 0.455 Very volatile Ebt Per Ebit 0.65 0.859 0.933 Pretty Stable Company Equity Multiplier 1.16 1.678 1.7192 Slightly volatile Long Term Debt To Capitalization 0.12 0.2139 0.2361 Slightly volatile Total Debt To Capitalization 0.3 0.284 0.265 Slightly volatile Debt Equity Ratio 0.42 0.3966 0.3983 Slightly volatile Quick Ratio 0.86 0.9037 2.1452 Slightly volatile Net Income Per E B T 0.92 0.8563 0.797 Pretty Stable Cash Ratio 0.41 0.4296 0.9201 Slightly volatile Cash Conversion Cycle 412 392 230 Slightly volatile Days Of Inventory Outstanding 201 389 273 Slightly volatile Days Of Sales Outstanding 78.72 70.496 65.6069 Slightly volatile Cash Flow Coverage Ratios 0.41 0.4337 1.1859 Slightly volatile Price To Book Ratio 1.27 1.3329 5.2905 Slightly volatile Fixed Asset Turnover 2.02 2.7351 3.3026 Pretty Stable Debt Ratio 0.25 0.2364 0.2105 Slightly volatile Cash Flow To Debt Ratio 0.41 0.4337 1.1859 Slightly volatile Price Sales Ratio 2.19 2.3027 10.4905 Slightly volatile Asset Turnover 0.33 0.345 0.4665 Pretty Stable Gross Profit Margin 0.5 0.7612 0.8077 Slightly volatile Price Fair Value 1.27 1.3329 5.2905 Slightly volatile
Biogen Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 9.4 B 11.6 B 11.9 B Pretty Stable Enterprise Value 9.4 B 11.6 B 11.9 B Pretty Stable

Biogen Fundamental Market Drivers

Biogen Upcoming Events

About Biogen Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen Details

Is Biogen Stock a good investment? Details

What is Biogen's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details